We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.64B
Cap. Flow %
-83.08%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169

Top Buys

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$604M
2
SPLK
Splunk Inc
SPLK
+$446M
3
HES
Hess
HES
+$339M
4
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$106M
5
X
US Steel
X
+$50.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$1.06B
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$887M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$371M
4
VMW
VMware, Inc
VMW
+$354M
5
NEWR
New Relic, Inc.
NEWR
+$284M

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Real Estate 7.26%
5 Industrials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RAPT
201
DELISTED
RAPT Therapeutics
RAPT
$1.54M 0.05%
7,736
-3,991
-34% -$494K
DASH icon
202
DoorDash
DASH
$92.4B
$1.48M 0.05%
+15,000
New +$1.33M
OCUL icon
203
Ocular Therapeutix
OCUL
$1.92B
$1.48M 0.05%
332,091
-10,020
-3% -$29.6K
MIRM icon
204
Mirum Pharmaceuticals
MIRM
$5.74B
$1.47M 0.05%
49,912
-11,088
-18% -$336K
RLAY icon
205
Relay Therapeutics
RLAY
$4.3B
$1.47M 0.05%
133,733
-13,113
-9% -$111K
XFOR icon
206
X4 Pharmaceuticals
XFOR
$393M
$1.46M 0.05%
58,101
+6,101
+12% +$148K
MTCH icon
207
Match Group
MTCH
$8.4B
$1.46M 0.05%
40,000
-10,000
-20% -$338K
LRMR icon
208
Larimar Therapeutics
LRMR
$436M
$1.46M 0.05%
319,901
-58,604
-15% -$198K
IONS icon
209
Ionis Pharmaceuticals
IONS
$9.06B
$1.45M 0.05%
28,624
-33,435
-54% -$1.6M
MGM icon
210
MGM Resorts International
MGM
$11.2B
$1.44M 0.05%
32,241
-17,259
-35% -$677K
PEN icon
211
Penumbra
PEN
$12.8B
$1.42M 0.04%
5,648
+4,279
+313% +$946K
ZYME icon
212
Zymeworks
ZYME
$1.7B
$1.42M 0.04%
136,313
-208,159
-60% -$1.66M
WEL
213
DELISTED
Integrated Wellness Acquisition Corp
WEL
$1.4M 0.04%
125,054
-56,209
-31% -$622K
ATEC icon
214
Alphatec Holdings
ATEC
$1.42B
$1.4M 0.04%
+92,821
New +$1.11M
ROK icon
215
Rockwell Automation
ROK
$49.1B
$1.4M 0.04%
+4,500
New +$1.26M
HCMA
216
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
$1.4M 0.04%
125,054
-56,209
-31% -$624K
WELL icon
217
Welltower
WELL
$170B
$1.36M 0.04%
15,117
-53,366
-78% -$4.63M
AGEN
218
Agenus
AGEN
$312M
$1.35M 0.04%
81,420
+9,216
+13% +$153K
PHM icon
219
Pultegroup
PHM
$24.7B
$1.33M 0.04%
+12,918
New +$1.1M
BCYC
220
Bicycle Therapeutics
BCYC
$278M
$1.33M 0.04%
73,601
-4,301
-6% -$71.2K
KIDS icon
221
OrthoPediatrics
KIDS
$596M
$1.31M 0.04%
40,314
-15,905
-28% -$461K
NFYS
222
DELISTED
Enphys Acquisition Corp.
NFYS
$1.31M 0.04%
122,826
-55,207
-31% -$585K
RIGL icon
223
Rigel Pharmaceuticals
RIGL
$733M
$1.3M 0.04%
89,934
-25,243
-22% -$258K
MRSN
224
DELISTED
Mersana Therapeutics
MRSN
$1.29M 0.04%
22,226
+10,369
+87% +$417K
ARDX icon
225
Ardelyx
ARDX
$1.2B
$1.27M 0.04%
204,600
-15,400
-7% -$69.1K
7 8
9
10 11

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.64B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.